Article
Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.
Leukemia - 1 Apr 1994
Neubauer A, Greenberg P, Negrin R, Ginzton N, Liu E
Abstract excerpt
Activation of the N- and K-ras proto-oncogenes is the most common molecular abnormality in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). In retrospective studies, approximately 3-36% of MDS patients were reported to harbor a mutated ras proto-oncogene, with some series suggesting the presence of ras-mutations are associated with progressive disease and a poor prognosis. Since hematopoietic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
